Oricula Therapeutics

0 followers


Oricula Therapeutics is working to develop the first medication to be approved to prevent drug-induced hearing loss.

Industries

Employees

1-10

Links


Org chart

Vince Groppi
Chief Executive Officer
Collapse
Graham Johnson
NuPharmAdvise, President
Marc Bailie
Chief Development Officer, INDS
David W. Raible
University of Washington, Professor